MiRNA-363-3p/DUSP10/JNK axis mediates chemoresistance by enhancing DNA damage repair in diffuse large B-cell lymphoma.

MiRNA-363-3p/DUSP10/JNK axis mediates chemoresistance by enhancing DNA damage repair in diffuse large B-cell lymphoma.
复制标题

miRNA-363-3p/dusp10/jnk轴通过增强弥漫性大型B细胞淋巴瘤中的DNA损伤修复来介导化学抗性。

DOI:
10.1038/s41375-022-01565-6
复制
发表时间:
2022-07
期刊:
影响因子:
11.4
通讯作者:
Liu, Yanyan
Liu, Yanyan
中科院分区:
医学1区
文献类型:
--
作者:
Zhou, Wenping;Xu, Yuanlin;Zhang, Jiuyang;Zhang, Peipei;Yao, Zhihua;Yan, Zheng;Wang, Haiying;Chu, Junfeng;Yao, Shuna;Zhao, Shuang;Yang, Shujun;Guo, Yongjun;Miao, Jinxin;Liu, Kangdong;Chan, Wing C.;Xia, Qingxin;Liu, Yanyan

文献摘要

参考文献

相似文献

基于蒽环类药物的化疗耐药性是弥漫性大B细胞淋巴瘤(DLBCL)的主要挑战。确定miRNA和基因表达谱(n = 47)以揭示潜在的化学抗性机制和治疗方法。miRNA-363- 3 p的高表达与化疗耐药性之间的独立相关性在更大的队列(n = 106)中被观察和验证。在体外和体内实验中,通过DLBCL细胞系中的异位表达和CRISPR/Cas9介导的敲除,miRNA-363- 3 p显示出减少阿霉素诱导的细胞凋亡和肿瘤缩小。发现DNA甲基化参与miRNA-363- 3 p的转录调控。进一步的研究表明,双特异性磷酸酶10(DUSP 10)是miRNA-363- 3 p的靶点,其抑制促进c-Jun N-末端激酶(JNK)的磷酸化。miRNA-363- 3 p/DUSP 10/JNK轴主要与同源重组(HR)和DNA修复途径的负调控相关。miRNA-363- 3 p的异位表达更有效地修复了阿霉素诱导的双链断裂(DSB),同时增强了非同源末端连接修复并减少了HR修复。靶向JNK和聚(ADP-核糖)聚合酶1显著抑制阿霉素诱导的DSB修复,增加阿霉素诱导的细胞凋亡和肿瘤缩小,并改善荷瘤小鼠的生存。总之,miRNA-363- 3 p/DUSP 10/JNK轴是DLBCL的一种新的化疗耐药机制,可以通过靶向治疗逆转。
Anthracycline-based chemotherapy resistance represents a major challenge in diffuse large B-cell lymphoma (DLBCL). MiRNA and gene expression profiles (n = 47) were determined to uncover potential chemoresistance mechanisms and therapeutic approaches. An independent correlation between high expression of miRNA-363-3p and chemoresistance was observed and validated in a larger cohort (n = 106). MiRNA-363-3p was shown to reduce doxorubicin-induced apoptosis and tumor shrinkage in in vitro and in vivo experiments by ectopic expression and CRISPR/Cas9-mediated knockout in DLBCL cell lines. DNA methylation was found to participate in transcriptional regulation of miRNA-363-3p. Further investigation revealed that dual specificity phosphatase 10 (DUSP10) is a target of miRNA-363-3p and its suppression promotes the phosphorylation of c-Jun N-terminal kinase (JNK). The miRNA-363-3p/DUSP10/JNK axis was predominantly associated with negative regulation of homologous recombination (HR) and DNA repair pathways. Ectopic expression of miRNA-363-3p more effectively repaired doxorubicin-induced double-strand break (DSB) while enhancing non-homologous end joining repair and reducing HR repair. Targeting JNK and poly (ADP-ribose) polymerase 1 significantly inhibited doxorubicin-induced DSB repair, increased doxorubicin-induced cell apoptosis and tumor shrinkage, and improved the survival of tumor-bearing mice. In conclusion, the miRNA-363-3p/DUSP10/JNK axis is a novel chemoresistance mechanism in DLBCL that may be reversed by targeted therapy.
DOI: 10.1128/mcb.01234-06
发表时间: 2007-03-01
影响因子: 5.3
作者:
Lu, Xiaoqing;Chen, Jun;Lossos, Izidore S.
通讯作者: Lossos, Izidore S.
DOI: 10.1038/s41591-018-0016-8
发表时间: 2018-05
期刊: Nature medicine
影响因子: 82.9
作者:
Chapuy B;Stewart C;Dunford AJ;Kim J;Kamburov A;Redd RA;Lawrence MS;Roemer MGM;Li AJ;Ziepert M;Staiger AM;Wala JA;Ducar MD;Leshchiner I;Rheinbay E;Taylor-Weiner A;Coughlin CA;Hess JM;Pedamallu CS;Livitz D;Rosebrock D;Rosenberg M;Tracy AA;Horn H;van Hummelen P;Feldman AL;Link BK;Novak AJ;Cerhan JR;Habermann TM;Siebert R;Rosenwald A;Thorner AR;Meyerson ML;Golub TR;Beroukhim R;Wulf GG;Ott G;Rodig SJ;Monti S;Neuberg DS;Loeffler M;Pfreundschuh M;Trümper L;Getz G;Shipp MA
通讯作者: Shipp MA
DOI: 10.1038/35000501
发表时间: 2000-02-03
期刊: NATURE
影响因子: 64.8
作者:
Alizadeh, AA;Eisen, MB;Staudt, LM
通讯作者: Staudt, LM
DOI: 10.1182/blood-2012-12-471722
发表时间: 2013-05-30
期刊: BLOOD
影响因子: 20.3
作者:
Li, Yong;Gordon, Michael W.;Young, Ken H.
通讯作者: Young, Ken H.
DOI: 10.1093/nar/gkt872
发表时间: 2014-01
影响因子: 14.9
作者:
Kuhar R;Gwiazda KS;Humbert O;Mandt T;Pangallo J;Brault M;Khan I;Maizels N;Rawlings DJ;Scharenberg AM;Certo MT
通讯作者: Certo MT